Liminatus Pharma Inc. Class A-28LIMNWPreferred / convertible

13F holders, Q2 2026 (June 30)
22holders +1
2new positions
1sold out
1famous investor
$0.06avg. 13F price*

At the end of Q2 2026, 22 institutions reported holding Liminatus Pharma Inc. Class A-28 (LIMNW) in their 13F filings, up 1 from Q1 2026. 2 opened new positions and 1 sold out. The largest holders were Aristeia Capital, L.L.C. ($16K), Linden Advisors LP ($14K) and Saba Capital Management, L.P. ($12K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).

Company
Liminatus Pharma Inc. Class A-28
CUSIP
53271X116
Latest filing quarter
Q2 2026

History

Number of 13F holders

0102030 Q2 2025: 25Q2 2025Q3 2025: 26Q3 2025Q4 2025: 24Q4 2025Q1 2026: 21Q1 2026Q2 2026: 22Q2 2026

Total Exit/New Position Q1 2026 → Q2 2026

InstitutionsTotal Value
New Positions2$2K
Exits1$4

All 13F filers, Q1 2026 → Q2 2026: 28,367 shares bought and 43,097 shares sold, net −14,730 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 22 holders
Aristeia Capital, L.L.C. — No change 319,510 $16K
Linden Advisors LP — No change 268,199 $14K
Saba Capital Management, L.P. — No change 233,761 $12K
Moore Capital Management, LP — No change 125,000 $9K
MMCAP International Inc. SPC — No change 111,745 $8K
Polar Asset Management Partners Inc. — No change 122,688 $6K
D. E. Shaw & Co. — No change 83,353 $3K
Toronto Dominion Bank — No change 35,100 $3K
LMR Partners LLP — No change 29,961 $2K
Arena Capital Advisors, LLC- CA — No change 29,166 $2K
Blue Owl Capital Holdings LP — No change 50,000 $2K
Periscope Capital Inc. — Reduce -36.8% 30,000 $2K
Jane Street Group, LLC — No change 24,274 $2K
Limestone Investment Advisors LP — No change 22,562 $2K
GTS Securities LLC — Reduce -0.5% 20,929 $2K
Susquehanna International Group, LLP — New 17,562 $1K
Wolverine Asset Management LLC — Reduce -64.5% 13,976 $1K
Flow Traders U.S. LLC — No change 13,110 $1K
Virtu Financial LLC — New 10,805 $1K
UBS Group AG — No change 4,507 $338
Dupont Capital Management Corp. — — 6,250 $318
HGC Investment Management Inc. — No change 1,250 $94

"% of holder's portfolio" is LIMNW's weight in each manager's 13F, not the share of Liminatus Pharma Inc. Class A-28 the manager owns.